Year |
Citation |
Score |
2009 |
Sugii S, Olson P, Sears DD, Saberi M, Atkins AR, Barish GD, Hong SH, Castro GL, Yin YQ, Nelson MC, Hsiao G, Greaves DR, Downes M, Yu RT, Olefsky JM, et al. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proceedings of the National Academy of Sciences of the United States of America. 106: 22504-9. PMID 20018750 DOI: 10.1073/Pnas.0912487106 |
0.482 |
|
2008 |
Barish GD, Atkins AR, Downes M, Olson P, Chong LW, Nelson M, Zou Y, Hwang H, Kang H, Curtiss L, Evans RM, Lee CH. PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 4271-6. PMID 18337509 DOI: 10.1073/Pnas.0711875105 |
0.448 |
|
2006 |
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM. PPARdelta regulates glucose metabolism and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 103: 3444-9. PMID 16492734 DOI: 10.1073/Pnas.0511253103 |
0.453 |
|
2004 |
Saez E, Rosenfeld J, Livolsi A, Olson P, Lombardo E, Nelson M, Banayo E, Cardiff RD, Izpisua-Belmonte JC, Evans RM. PPAR gamma signaling exacerbates mammary gland tumor development. Genes & Development. 18: 528-40. PMID 15037548 DOI: 10.1101/Gad.1167804 |
0.382 |
|
2003 |
He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proceedings of the National Academy of Sciences of the United States of America. 100: 15712-7. PMID 14660788 DOI: 10.1073/Pnas.2536828100 |
0.45 |
|
2003 |
Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific Pparg deletion causes insulin resistance. Nature Medicine. 9: 1491-7. PMID 14625542 DOI: 10.1038/Nm956 |
0.454 |
|
2003 |
Saez E, Olson P, Evans RM. Genetic deficiency in Pparg does not alter development of experimental prostate cancer. Nature Medicine. 9: 1265-6. PMID 12960963 DOI: 10.1038/Nm928 |
0.388 |
|
2003 |
Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 144: 2201-7. PMID 12746275 DOI: 10.1210/En.2003-0288 |
0.48 |
|
Show low-probability matches. |